Table 1.
Expression Levels in CVD Patients | Function in CVDs | Target Genes | |
---|---|---|---|
miR-155 | Up [71,72] Down [73,74] |
Pathogenic | eNOS SIRT1 |
miR-15/16 | Up [75] Down [76] |
Controversial | eNOS SIRT1 (possible) |
miR-221/222 | Up [40,77,78,79] Down [80,81] |
Protective | eNOS SOD2 |
miR-21 | Up [45,77,81,82,83,84] | Controversial | eNOS SOD2 |
miR-199a | Up [44,85] Down [86] |
Controversial | SIRT1 SOD1 eNOS (indirectly) |
miR-34a | Up [39,45,84,87,88] | Pathogenic | SIRT1 |
miR-145 | Down [46,89] | Protective | SIRT1 |
miR-210 | Up [41,45,81,90,91] | Controversial | SIRT1 |
miR-126 | Down [44,74,92,93] | Protective | SOD SIRT1 (possible) |